Coeptis Therapeutics' SNAP-CAR Technology Platform for Progr

SNAP-CAR represents a major advance potentially expanding the targeting capabilities of chimeric antigen receptor T cells for various cancers and other indications
WEXFORD, Pa., May 10, 2023... | June 15, 2023

Related Keywords

, Jon Nugent , Jason Lohmueller , Dave Mehalick , Karolinska Institutet , David Schemelia , University Of Pittsburgh , Drug Administration , Prnewswire Coeptis Therapeutics Holdings Inc , Nature Communications , Coeptis Therapeutics Inc , Coeptis Pharmaceuticals Inc , Coeptis Therapeutics Holdings Inc , Securities Exchange , Holdings Inc , Division Of Surgical Oncology Research , Exchange Commission , Nasdaq , Therapeutics Holdings , Assistant Professor , Surgical Oncology Research , Coeptis Therapeutics , Coeptis Therapeutics Holdings , Coeptis Pharmaceuticals , Deverra Therapeutics , Securities Act , Securities Exchange Act , Nasdaq Global Market ,